皓元医药
(688131)
| 流通市值：81.61亿 | | | 总市值：83.50亿 |
| 流通股本：2.06亿 | | | 总股本：2.11亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,066,699,355.86 | 879,553,866.26 | 497,446,645.4 | 442,230,962.84 |
| 应收票据及应收账款 | 615,763,224.84 | 542,724,575.24 | 585,226,098.92 | 565,075,630.25 |
| 其中：应收票据 | 18,860,214.2 | 20,652,172.72 | 15,228,405.74 | 7,561,927.92 |
| 应收账款 | 596,903,010.64 | 522,072,402.52 | 569,997,693.18 | 557,513,702.33 |
| 应收款项融资 | 12,974,243.25 | 17,397,038.45 | 9,880,643.75 | 7,028,199.04 |
| 预付款项 | 16,958,773.48 | 13,183,434.6 | 22,105,521.81 | 17,316,006.13 |
| 其他应收款合计 | 28,438,140.36 | 30,565,123.45 | 51,286,796.09 | 16,770,545.83 |
| 存货 | 1,236,137,112.17 | 1,162,550,788.68 | 1,151,625,343.23 | 1,101,699,839.46 |
| 合同资产 | 43,226,751.19 | 38,101,088.08 | 37,414,607.37 | 39,373,931.04 |
| 其他流动资产 | 42,855,465.71 | 41,692,789.45 | 21,894,931.13 | 38,364,339.75 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 3,363,203,135.35 | 3,174,918,772.7 | 2,376,880,587.7 | 2,227,859,454.34 |
| 非流动资产: | | | | |
| 长期股权投资 | 125,627,047.81 | 126,700,969.08 | 58,054,499.99 | 57,843,889.82 |
| 其他权益工具投资 | 48,118,336.42 | 40,118,336.42 | 69,863,796.74 | 66,958,761.04 |
| 其他非流动金融资产 | 13,000,000 | 13,000,000 | 13,000,000 | 13,000,000 |
| 固定资产 | 853,363,208.41 | 872,687,928.78 | 828,052,251.67 | 836,776,028.02 |
| 在建工程 | 300,905,323.27 | 272,745,689.86 | 264,636,567.05 | 279,589,080.82 |
| 使用权资产 | 303,630,055.56 | 304,167,303.53 | 362,325,876.43 | 193,190,104.94 |
| 无形资产 | 111,844,399.92 | 114,048,590.85 | 113,436,200.22 | 114,573,275.44 |
| 商誉 | 301,182,973.14 | 301,182,973.14 | 301,182,973.14 | 301,182,973.14 |
| 长期待摊费用 | 123,329,615.66 | 130,406,715.83 | 125,716,016.3 | 125,652,113.6 |
| 递延所得税资产 | 149,699,092.68 | 135,935,522.88 | 150,202,937.59 | 137,144,008.63 |
| 其他非流动资产 | 19,625,707 | 19,033,092.2 | 20,150,938.57 | 18,880,424.32 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,350,325,759.87 | 2,330,027,122.57 | 2,306,622,057.7 | 2,144,790,659.77 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 5,713,528,895.22 | 5,504,945,895.27 | 4,683,502,645.4 | 4,372,650,114.11 |
| 流动负债: | | | | |
| 短期借款 | 687,706,433.32 | 539,383,479.4 | 545,330,211.25 | 529,335,564.65 |
| 应付票据及应付账款 | 303,250,228.41 | 337,781,731.87 | 272,799,401.46 | 251,714,097.69 |
| 其中：应付票据 | - | 3,000,000 | 3,000,000 | 7,417,599.2 |
| 应付账款 | 303,250,228.41 | 334,781,731.87 | 269,799,401.46 | 244,296,498.49 |
| 合同负债 | 69,861,796.8 | 70,602,091.2 | 80,342,601.78 | 73,289,220.74 |
| 应付职工薪酬 | 111,679,771.47 | 104,652,445.95 | 108,913,008.95 | 99,257,800.25 |
| 应交税费 | 48,654,839.92 | 68,279,072.31 | 60,327,150.29 | 46,090,107.44 |
| 其他应付款合计 | 4,885,079.51 | 4,904,978.45 | 15,146,264.18 | 8,949,341.11 |
| 应付股利 | - | - | 8,437,155.36 | - |
| 一年内到期的非流动负债 | 117,394,221.24 | 119,854,779.16 | 113,446,336.74 | 120,312,583.94 |
| 其他流动负债 | 20,419,386.19 | 14,728,713.46 | 13,699,444.75 | 7,962,021.64 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,363,851,756.86 | 1,260,187,291.8 | 1,210,004,419.4 | 1,136,910,737.46 |
| 非流动负债: | | | | |
| 长期借款 | 282,520,000 | 249,529,064.16 | 287,874,064.16 | 288,374,064.16 |
| 应付债券 | 708,531,720.13 | 701,929,677.5 | - | - |
| 租赁负债 | 299,570,301.94 | 295,206,405.47 | 347,979,379.85 | 180,998,942.81 |
| 长期应付款 | 27,874,249.86 | 34,105,234.17 | 41,399,039.22 | 47,517,853.3 |
| 递延收益 | 57,821,240.29 | 59,733,291.24 | 60,814,627.84 | 61,948,054.86 |
| 递延所得税负债 | - | - | 13,710,691.25 | 14,003,248.04 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,376,317,512.22 | 1,340,503,672.54 | 751,777,802.32 | 592,842,163.17 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,740,169,269.08 | 2,600,690,964.34 | 1,961,782,221.72 | 1,729,752,900.63 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 210,959,781 | 210,959,781 | 210,928,884 | 210,542,274 |
| 其他权益工具 | 112,302,037.34 | 112,302,037.34 | - | - |
| 资本公积 | 1,682,059,099.31 | 1,676,238,579.31 | 1,682,612,351.93 | 1,665,579,271.64 |
| 其他综合收益 | 26,041,394.19 | 25,841,008.65 | 17,202,590.55 | 16,005,002.89 |
| 专项储备 | 8,021,330.95 | 6,115,834.94 | 5,258,068.4 | 5,439,988.97 |
| 盈余公积 | 24,928,234.59 | 24,928,234.59 | 19,496,653.59 | 19,496,653.59 |
| 未分配利润 | 883,876,069.13 | 821,491,669.11 | 768,681,134.66 | 704,178,005.46 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,948,187,946.51 | 2,877,877,144.94 | 2,704,179,683.13 | 2,621,241,196.55 |
| 少数股东权益 | 25,171,679.63 | 26,377,785.99 | 17,540,740.55 | 21,656,016.93 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,973,359,626.14 | 2,904,254,930.93 | 2,721,720,423.68 | 2,642,897,213.48 |
| 负债和股东权益合计 | 5,713,528,895.22 | 5,504,945,895.27 | 4,683,502,645.4 | 4,372,650,114.11 |
| 公告日期 | 2025-04-30 | 2025-03-28 | 2024-10-30 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |